Evidence map›Paper›PMID 31835729›Full record

ArticleJournal of clinical medicine2019

Retinal Microperimetry: A Useful Tool for Detecting Insulin Resistance-Related Cognitive Impairment in Morbid Obesity.

Andreea Ciudin, Angel Michael Ortiz, Enzamaria Fidilio, Diana Romero, Marta Sánchez, Marta Comas, Oscar Gonzalez, Ramon Vilallonga, Olga Simó-Servat, Cristina Hernández and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Andreea CiudinInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Plaça Cívica, Barcelona 08193, Spain.ORCID 0000-0001-5622-0203
Angel Michael OrtizInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Plaça Cívica, Barcelona 08193, Spain.
Enzamaria FidilioInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Plaça Cívica, Barcelona 08193, Spain.
Diana RomeroInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Plaça Cívica, Barcelona 08193, Spain.
Marta SánchezDepartment of Endocrinology, Vall d'Hebron University Hospital. Passeig Vall d'Hebron 119-139, Barcelona 08035, Spain.
Marta ComasDepartment of Endocrinology, Vall d'Hebron University Hospital. Passeig Vall d'Hebron 119-139, Barcelona 08035, Spain.
Oscar GonzalezDepartment of Surgery. Vall d'Hebron University Hospital. Passeig Vall d'Hebron 119-139, Barcelona 08035, Spain.ORCID 0000-0002-2597-9257
Ramon VilallongaDepartment of Surgery. Vall d'Hebron University Hospital. Passeig Vall d'Hebron 119-139, Barcelona 08035, Spain.
Olga Simó-ServatInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Plaça Cívica, Barcelona 08193, Spain.
Cristina HernándezInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Plaça Cívica, Barcelona 08193, Spain.ORCID 0000-0002-3109-1721
Rafael SimóInstitut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona (VHIR-UAB), Plaça Cívica, Barcelona 08193, Spain.ORCID 0000-0003-0475-3096
Universitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ES

Funding

Fondazione Internazionale Menarini 2/2018
6 · The paper itself

Abstract

backgroundThere is clear association between type 2 diabetes (T2D) and cognitive decline. Retinal microperimetry is a useful tool for detecting cognitive impairment in T2D. Morbid obesity (MO) has been associated with cognitive impairment. Insulin resistance (IR) seems a major determinant, but the data are unclear. The aim of this study was to evaluate the cognitive impairment in MO as well as the utility of retinal microperimetry in identifying these alterations.

methodsIn total, 50 consecutive patients with MO were matched by age and gender with 30 healthy controls. All patients underwent cognitive evaluation (Montreal Cognitive Assessment Test-MoCA) and retinal microperimetry, using MAIA microperimeter 3rd generation. Retinal sensitivity and gaze fixation parameters were used for the evaluation of the analysis.

resultsMO patients showed a significantly lower neurocognitive performance than the controls: MoCA score 24.94 ± 2.74 vs. 28.95 ± 1.05,

conclusions(1) Systemic insulin resistance is a major underlying mechanism accounting for the higher prevalence of cognitive impairment detected in young MO subjects. (2) Retinal microperimetry is a useful tool for identifying MO patients with cognitive impairment.

Indexed as

cognitive impairmentinsulin resistancemorbid obesityretinal microperimetry

Identifiers

PMID31835729
PMCPMC6947364
OpenAlexW2995773737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.